Immediate Impact
1 by Nobel laureates 69 standout
Citing Papers
Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Michael Stahl being referenced
Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Stahl | 182 | 87 | 67 | 84 | 18 | 277 | |
| Luigi Serra | 183 | 57 | 28 | 53 | 15 | 303 | |
| L. Pétriz | 89 | 141 | 69 | 101 | 12 | 325 | |
| Seung Woo Yi | 127 | 89 | 60 | 35 | 18 | 319 | |
| Albert Su | 151 | 40 | 31 | 48 | 17 | 282 | |
| Sumika Matsukita | 97 | 45 | 26 | 51 | 12 | 274 | |
| Olga L. Bohn | 135 | 78 | 22 | 63 | 17 | 336 | |
| Christian De Potter | 114 | 47 | 9 | 57 | 14 | 260 | |
| Kohei Akiyoshi | 209 | 59 | 49 | 94 | 25 | 290 | |
| Shogo Urabe | 94 | 107 | 7 | 86 | 27 | 271 | |
| Samhita Chakraborty | 224 | 25 | 64 | 110 | 17 | 306 |
All Works
Loading papers...